Biomarker Commercialization

On the spectrum of difficulty, I would argue, Diagnostic innovation is by far one of the most challenging spaces in which to develop novel commercial concepts. To ease and structure the complex process, a European Consortium has been working on the development of several documents and a support tool to guide would-be founders on the technical, regulatory and commercial development of diagnostic tools.

For those interested, please have a look at the link found below: